調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Protein Sequencing Market by Product (Sample Preparation, MS, Sequencer, Reagent, Consumable), Service, Technology (MS, Edman), Application (Biotherapeutics, Genetic Engineering), Enduser (Academia, Pharma, Biotechnology, CROs) - Global Forecast to 2023

タンパク質シーケンシングの世界市場予測（～2023年）

◆タイトル：Protein Sequencing Market by Product (Sample Preparation, MS, Sequencer, Reagent, Consumable), Service, Technology (MS, Edman), Application (Biotherapeutics, Genetic Engineering), Enduser (Academia, Pharma, Biotechnology, CROs) - Global Forecast to 2023
◆商品コード：BT-6751
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年11月19日
◆ページ数：119
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオテクノロジー
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥880,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

タンパク質シーケンシングの世界市場は、2018年の9億2500万米ドルから2023年には10億8800万米ドルに達し、この期間中3.3%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、プロテオミクス研究に対する政府および民間団体からの財政支援、臨床質量分析および解析技術の進歩、製薬・バイオテクノロジー企業によるターゲットベースの医薬品開発の増加などが考えれられます。一方で、高いインフラコストにより、市場の成長は抑制される可能性があります。当調査レポートでは、タンパク質シーケンシングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（サンプル調製、MS、シーケンサー、試薬、消耗品）分析、サービス分析、技術（MS、エドマン）分析、用途（バイオ療法、遺伝子工学）分析、タンパク質シーケンシングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Global protein sequencing market to register a CAGR of 3.3% from 2018 to 2023”
The global protein sequencing market is projected to reach USD 1,088 million by 2023 from USD 925 million in 2018, at a CAGR of 3.3% during the forecast period. Factors such as financial support from government and private bodies for proteomic research, advancements in clinical mass spectrometry and analytical techniques, and significant adoption of target-based drug development by pharmaceutical and biotechnology companies are expected to propel the growth of this market. However, high infrastructure costs are expected to restrain the growth of the protein sequencing market in the forecast period.

“Mass spectrometry technology segment to dominate the protein sequencing market in 2018”
By technology, the protein sequencing market is segmented into mass spectrometry and Edman degradation. The mass spectrometry segment is expected to command the largest share of the protein sequencing market in 2018. The large share of this segment can be attributed to the advantages of mass spectrometry, such as high-throughput sequencing capabilities, cost efficiency, and identification of blocked or modified proteins. Market growth can also be attributed to the increasing focus of market players on launching technologically advanced mass spectrometry instruments and the increasing applications of mass spectrometry in proteomics research.

“Academic institutes and research centers to register the highest CAGR during 2018–2023”
On the basis of end user, the protein sequencing market is segmented into academic institutes & research centers, pharmaceutical & biotechnology companies, and other end users. Academic institutes & research centers are estimated to witness the highest growth rate during the forecast period. Growth in this segment can be attributed to the increase in funding for proteomic research by public and private institutes.

“The protein sequencing market in the APAC is projected to witness the highest growth rate during the forecast period”
The protein sequencing market in the Asia Pacific is expected to witness the highest CAGR from 2018 to 2023. Factors such the availability of government funding for life science research, advanced sequencing infrastructure in research organizations, and the presence of a large number of protein sequencing service providers in the region are driving the growth of the protein sequencing market in the APAC region.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (33%), Tier 2 (47%), and Tier 3 (22%)
• By Designation: C-level (48%), Director-level (19%), and Others (33%)
• By Region: North America (31%), Europe (33%), APAC (19%), and RoW (17%)

The key players in the protein sequencing market are Shimadzu (Japan), Thermo Fisher Scientific Inc. (US), SGS S.A. (Switzerland), Waters Corporation (US), Rapid Novor (Canada), Agilent Technologies (US), Charles River Laboratories (US), and Selvita (Poland).

Research Coverage
This report studies the protein sequencing market based on product & service, technology, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on business strategies adopted by the major players in the protein sequencing market. The report analyzes the protein sequencing market based on product & service, technology, application, end user, and region

• Product Launches: Insights on the research and development activities and product & service launches in the protein sequencing market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various protein sequencing types across regions

• Market Diversification: Exhaustive information about recent developments and investments in the protein sequencing market

• Competitive Assessment: In-depth assessment of market shares, strategies, and products of leading players in the protein sequencing market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY RESEARCH 20
2.1.2.1 Key data from primary sources 21
2.1.2.1.1 Breakdown of Primary Interviews 21
2.2 MARKET SIZE ESTIMATION 22
2.2.1 REVENUE-BASED MARKET ESTIMATION 22
2.2.2 END-USER-BASED MARKET ESTIMATION 22
2.2.3 PRIMARY RESEARCH VALIDATION 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 ASSUMPTIONS FOR THE STUDY 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 30
4.1 PROTEIN SEQUENCING MARKET OVERVIEW 30
4.2 PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE (2018 VS. 2023) 30
4.3 PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018 VS. 2023 31
4.4 PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018 VS. 2023 31
4.5 PROTEIN SEQUENCING MARKET, BY END USER, 2018 VS. 2023 32
 
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 Increasing focus on target-based drug development by pharmaceutical and biotechnology companies 34
5.2.1.2 Advancements in clinical mass spectrometry and analytical techniques 34
5.2.1.3 Increasing public-private financial support for proteomic research 34
5.2.2 RESTRAINTS 35
5.2.2.1 High infrastructure costs 35
5.2.3 OPPORTUNITIES 36
5.2.3.1 Technological advancements for the identification of isobaric residues in protein sequences 36
5.2.4 CHALLENGES 36
5.2.4.1 Preparation of pure protein samples 36
5.2.4.2 Need for skilled researchers and laboratory professionals 36
6 PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE 37
6.1 INTRODUCTION 38
6.2 SAMPLE PREPARATION PRODUCTS & SERVICES 39
6.2.1 GROWING NEED FOR STANDARDIZED SAMPLE PREPARATION SOLUTIONS IS A MAJOR DRIVER FOR THE SAMPLE PREPARATION PRODUCTS & SERVICES MARKET 39
6.3 PROTEIN SEQUENCING PRODUCTS 40
6.3.1 REAGENTS & CONSUMABLES 41
6.3.1.1 Growing number of sequencing procedures to drive the demand for protein sequencing reagents & consumables 41
6.3.2 INSTRUMENTS 41
6.3.2.1 Mass spectrometry instruments 42
6.3.2.1.1 Technological advancements to drive the adoption of mass spectrometry instruments 42
6.3.2.2 Edman degradation sequencers 43
6.3.2.2.1 High accuracy of Edman degradation method to drive the adoption of these products 43
6.3.3 ANALYSIS PRODUCTS/SOFTWARE 44
6.3.3.1 Protein sequencing analysis products/software to witness the highest growth rate during the forecast period 44
6.4 PROTEIN SEQUENCING SERVICES 45
6.4.1 PROTEIN SEQUENCING SERVICES TO REGISTER THE HIGHEST GROWTH BETWEEN 2018 & 2023 45
 
7 PROTEIN SEQUENCING MARKET, BY TECHNOLOGY 46
7.1 INTRODUCTION 47
7.2 MASS SPECTROMETRY 48
7.2.1 HIGH-THROUGHPUT SEQUENCING CAPABILITIES AND COST EFFICIENCY TO DRIVE THE ADOPTION OF MASS SPECTROMETRY PROTEIN SEQUENCING 48
7.3 EDMAN DEGRADATION 49
7.3.1 HIGH ACCURACY OF THE EDMAN DEGRADATION METHOD IS THE KEY FACTOR DRIVING ITS ADOPTION IN THE MARKET 49
8 PROTEIN SEQUENCING MARKET, BY APPLICATION 50
8.1 INTRODUCTION 51
8.2 BIOTHERAPEUTICS 52
8.2.1 BIOTHERAPEUTICS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 52
8.3 GENETIC ENGINEERING 52
8.3.1 LARGE NUMBER OF RESEARCH PROJECTS FOCUSED ON GENETICALLY MODIFIED ORGANISMS & TECHNOLOGICAL ADVANCEMENTS—KEY FACTORS DRIVING MARKET GROWTH 52
8.4 OTHER APPLICATIONS 54
9 PROTEIN SEQUENCING MARKET, BY END USER 56
9.1 INTRODUCTION 57
9.2 ACADEMIC INSTITUTES & RESEARCH CENTERS 58
9.2.1 ACADEMIC INSTITUTES & RESEARCH CENTERS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET OWING TO THE INCREASING FUNDING FOR PROTEOMICS RESEARCH 58
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 60
9.3.1 INCREASING R&D EXPENDITURE OF MAJOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH 60
9.4 OTHER END USERS 61
10 PROTEIN SEQUENCING MARKET, BY REGION 62
10.1 INTRODUCTION 63
10.2 NORTH AMERICA 64
10.2.1 US 67
10.2.1.1 Launch of advanced protein sequencing products & the strong presence of leading players are driving the growth of the protein sequencing market in the US 67
10.2.2 CANADA 68
10.2.2.1 Financial support from government and private organizations for R&D in the proteomics field—major factor supporting market growth 68
10.3 EUROPE 69
10.3.1 GERMANY 72
10.3.1.1 Favorable funding scenario for life science research to drive the growth of the protein sequencing market in Germany 72
10.3.2 FRANCE 72
10.3.2.1 Rising demand for biotherapeutics and biotechnology in the country to drive the adoption of protein sequencing 72
10.3.3 UK 73
10.3.3.1 Presence of a large life sciences industry and the continued growth of the biopharmaceuticals sector are the major factors driving market growth 73
10.3.4 REST OF EUROPE 74
10.4 ASIA PACIFIC 75
10.4.1 CHINA 78
10.4.1.1 China to register the highest growth in the Asia Pacific protein sequencing market during the forecast period 78
10.4.2 JAPAN 78
10.4.2.1 Strong life sciences R&D infrastructure and a favorable government funding scenario are key factors driving market growth 78
10.4.3 INDIA 79
10.4.3.1 Implementation of favorable government initiatives to support life sciences research to support the growth of the protein sequencing market in India 79
10.4.4 REST OF ASIA PACIFIC 80
10.5 REST OF THE WORLD 81
11 COMPETITIVE LANDSCAPE 84
11.1 OVERVIEW 84
11.2 MARKET SHARE ANALYSIS 85
11.3 COMPETITIVE SITUATION AND TRENDS 86
11.3.1 PRODUCT LAUNCHES AND SERVICES 86
11.3.2 PARTNERSHIPS 87
11.3.3 ACQUISITIONS 87
11.3.4 EXPANSIONS 88
12 COMPANY PROFILES 89

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 AGILENT TECHNOLOGIES, INC. 89
12.2 BIOINFORMATICS SOLUTIONS 91
12.3 CHARLES RIVER LABORATORIES 92
12.4 PROTEOME FACTORY 94
12.5 RAPID NOVOR INC. 95
12.6 SELVITA 97
12.7 SGS 99
 
12.8 SHIMADZU CORPORATION 101
12.9 THERMO FISHER SCIENTIFIC INC. 105
12.10 WATERS 109

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 111
13.1 DISCUSSION GUIDE 111
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 115
13.3 AVAILABLE CUSTOMIZATIONS 117
13.4 RELATED REPORTS 117
13.5 AUTHOR DETAILS 118

LIST OF TABLES

TABLE 1 PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 38
TABLE 2 SAMPLE PREPARATION PRODUCTS & SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 39
TABLE 3 PROTEIN SEQUENCING PRODUCTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 40
TABLE 4 PROTEIN SEQUENCING PRODUCTS MARKET, BY REGION,
2016–2023 (USD MILLION) 40
TABLE 5 REAGENTS & CONSUMABLES MARKET, BY REGION, 2016–2023 (USD MILLION) 41
TABLE 6 INSTRUMENTS MARKET, BY TYPE, 2016–2023 (USD MILLION) 42
TABLE 7 INSTRUMENTS MARKET, BY REGION, 2016–2023 (USD MILLION) 42
TABLE 8 ANALYSIS PRODUCTS/SOFTWARE MARKET, BY REGION,
2016–2023 (USD MILLION) 44
TABLE 9 PROTEIN SEQUENCING SERVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 45
TABLE 10 PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 47
TABLE 11 MASS SPECTROMETRY PROTEIN SEQUENCING MARKET, BY REGION,
2016–2023 (USD MILLION) 48
TABLE 12 EDMAN DEGRADATION PROTEIN SEQUENCING MARKET, BY REGION,
2016–2023 (USD MILLION) 49
TABLE 13 PROTEIN SEQUENCING MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 51
TABLE 14 PROTEIN SEQUENCING MARKET FOR BIOTHERAPEUTICS, BY REGION,
2016–2023 (USD MILLION) 52
TABLE 15 PROTEIN SEQUENCING MARKET FOR GENETIC ENGINEERING, BY REGION,
2016–2023 (USD MILLION) 53
TABLE 16 PROTEIN SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION,
2016–2023 (USD MILLION) 55
TABLE 17 PROTEIN SEQUENCING MARKET, BY END USER, 2016–2023 (USD MILLION) 57
TABLE 18 PROTEIN SEQUENCING MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2016–2023 (USD MILLION) 59
TABLE 19 PROTEIN SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION) 60
TABLE 20 PROTEIN SEQUENCING MARKET FOR OTHER END USERS, BY REGION,
2016–2023 (USD MILLION) 61
TABLE 21 PROTEIN SEQUENCING MARKET, BY REGION, 2016–2023 (USD MILLION) 63
TABLE 22 NORTH AMERICA: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 65
TABLE 23 NORTH AMERICA: PROTEIN SEQUENCING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 65
TABLE 24 NORTH AMERICA: PROTEIN SEQUENCING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 65
TABLE 25 NORTH AMERICA: PROTEIN SEQUENCING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 66
TABLE 26 NORTH AMERICA: PROTEIN SEQUENCING MARKET, BY END USER,
2016–2023 (USD MILLION) 66
TABLE 27 NORTH AMERICA: PROTEIN SEQUENCING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 66
TABLE 28 US: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 67
TABLE 29 CANADA: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 68
TABLE 30 EUROPE: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 70
TABLE 31 EUROPE: PROTEIN SEQUENCING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 70
TABLE 32 EUROPE: PROTEIN SEQUENCING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 70
TABLE 33 EUROPE: PROTEIN SEQUENCING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 71
TABLE 34 EUROPE: PROTEIN SEQUENCING MARKET, BY END USER,
2016–2023 (USD MILLION) 71
TABLE 35 EUROPE: PROTEIN SEQUENCING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 71
TABLE 36 GERMANY: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 72
TABLE 37 FRANCE: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 73
TABLE 38 UK: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 73
TABLE 39 REST OF EUROPE: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 74
TABLE 40 ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 76
TABLE 41 ASIA PACIFIC: PROTEIN SEQUENCING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 76
TABLE 42 ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 76
TABLE 43 ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 77
TABLE 44 ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY END USER,
2016–2023 (USD MILLION) 77
TABLE 45 ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 77
TABLE 46 CHINA: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 78
TABLE 47 JAPAN: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 79
TABLE 48 INDIA: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 80
TABLE 49 REST OF ASIA PACIFIC: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 80
TABLE 50 ROW: PROTEIN SEQUENCING MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 82
TABLE 51 ROW: PROTEIN SEQUENCING PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 82
TABLE 52 ROW: PROTEIN SEQUENCING MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 82
 
TABLE 53 ROW: PROTEIN SEQUENCING MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 83
TABLE 54 ROW: PROTEIN SEQUENCING MARKET, BY END USER, 2016–2023 (USD MILLION) 83
TABLE 55 KEY PRODUCT AND SERVICE LAUNCHES 2017–2018 (OCTOBER) 86
TABLE 56 KEY PARTNERSHIPS, 2017–2018 (OCTOBER) 87
TABLE 57 KEY ACQUISITIONS, 2017–2018 (OCTOBER) 87
TABLE 58 KEY GEOGRAPHIC EXPANSIONS, 2017–2018 (OCTOBER) 88


LIST OF FIGURES

FIGURE 1 PROTEIN SEQUENCING MARKET: RESEARCH DESIGN 19
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & REGION 21
FIGURE 3 MARKET SIZE ESTIMATION: PROTEIN SEQUENCING MARKET 23
FIGURE 4 DATA TRIANGULATION METHODOLOGY 24
FIGURE 5 PROTEIN SEQUENCING MARKET SHARE, BY APPLICATION, 2018 VS. 2023 26
FIGURE 6 PROTEIN SEQUENCING MARKET SHARE, BY PRODUCT & SERVICE, 2018 VS. 2023 27
FIGURE 7 PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD MILLION) 27
FIGURE 8 PROTEIN SEQUENCING MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 28
FIGURE 9 PROTEIN SEQUENCING MARKET: GEOGRAPHICAL SNAPSHOT 28
FIGURE 10 SIGNIFICANT ADOPTION OF TARGET-BASED DRUG DEVELOPMENT APPROACHES
TO DRIVE MARKET GROWTH 30
FIGURE 11 PROTEIN SEQUENCING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE MAJOR SHARE DURING FORECAST PERIOD 30
FIGURE 12 MASS SPECTROMETRY WILL CONTINUE TO DOMINATE THE PROTEIN SEQUENCING MARKET IN 2023 31
FIGURE 13 BIOTHERAPEUTICS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE STUDY PERIOD 31
FIGURE 14 ACADEMIC INSTITUTES AND RESEARCH CENTERS TO DOMINATE THE PROTEIN SEQUENCING MARKET IN THE FORECAST PERIOD 32
FIGURE 15 PROTEIN SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 33
FIGURE 16 NIH RESEARCH GRANTS FOR RESEARCH IN LIFE SCIENCES, 2013–2017 (USD BILLION) 35
FIGURE 17 PROTEIN SEQUENCING SERVICES ARE EXPECTED TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 38
FIGURE 18 MASS SPECTROMETRY TO DOMINATE THE PROTEIN SEQUENCING MARKET DURING THE FORECAST PERIOD 47
FIGURE 19 BIOTHERAPEUTICS IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 51
FIGURE 20 NUMBER OF RESEARCH PUBLICATIONS ON GENETICALLY MODIFIED ORGANISMS (2007-2017) 53
FIGURE 21 GROWTH IN THE NUMBER OF KNOWN PROTEIN STRUCTURES AVAILABLE IN PROTEIN DATA BANK DATABASE 54
FIGURE 22 ACADEMIC INSTITUTES & RESEARCH CENTERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018–2023) 57
FIGURE 23 KEY ACADEMIC PROTEIN SEQUENCING SERVICE PROVIDERS 58
FIGURE 24 FUNDING FOR PROTEOMIC RESEARCH, 1987–2017 (USD MILLION) 59
FIGURE 25 NORTH AMERICA: PROTEIN SEQUENCING MARKET SNAPSHOT 64
FIGURE 26 EUROPE: PROTEIN SEQUENCING MARKET SNAPSHOT 69
FIGURE 27 ASIA PACIFIC: PROTEIN SEQUENCING MARKET SNAPSHOT 75
FIGURE 28 ROW: PROTEIN SEQUENCING MARKET SNAPSHOT 81
FIGURE 29 KEY DEVELOPMENTS IN THE PROTEIN SEQUENCING MARKET
FROM JAN 2015 TO OCTOBER 2018 84
FIGURE 30 PROTEIN SEQUENCING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017 85
FIGURE 31 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2017) 89
FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2017) 92
FIGURE 33 SELVITA: COMPANY SNAPSHOT (2017) 97
FIGURE 34 SGS: COMPANY SNAPSHOT (2017) 99
FIGURE 35 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2017) 101
FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 105
FIGURE 37 WATERS: COMPANY SNAPSHOT (2017) 109


★調査レポート[タンパク質シーケンシングの世界市場予測（～2023年）] ( Protein Sequencing Market by Product (Sample Preparation, MS, Sequencer, Reagent, Consumable), Service, Technology (MS, Edman), Application (Biotherapeutics, Genetic Engineering), Enduser (Academia, Pharma, Biotechnology, CROs) - Global Forecast to 2023 / BT-6751) 販売に関する免責事項
[タンパク質シーケンシングの世界市場予測（～2023年）] ( Protein Sequencing Market by Product (Sample Preparation, MS, Sequencer, Reagent, Consumable), Service, Technology (MS, Edman), Application (Biotherapeutics, Genetic Engineering), Enduser (Academia, Pharma, Biotechnology, CROs) - Global Forecast to 2023 / BT-6751) についてEメールでお問い合わせ
◆関連調査資料◆
  • トランスファーメンブレンの世界市場予測（～2023年）：PVDF、ニトロセルロース、ナイロン
    BT-6377 / MarketsandMarkets / 2018年6月15日 / MarketsandMarketsが発行した当調査レポートでは、トランスファーメンブレンの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類（PVDF、ニトロセルロース、ナイロン）別分析、トランスファー方法別分析、用途別分析、需要先別分析、トランスファーメンブレンの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global transfer membrane market is expected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period. Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of transfer membrane market. The report analyzes the global transfer membrane market by type, transfer method, application, end user, and region. On the basis of type, the transfer membrane market is divided into nylon...
  • マルチプレックスアッセイの世界市場予測（～2023年）
    BT-4473 / MarketsandMarkets / 2018年6月7日 / MarketsandMarketsが発行した当調査レポートでは、マルチプレックスアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（消耗品、装置）別分析、種類別分析、技術別分析、用途（研究開発、診断）別分析、マルチプレックスアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.33 Billion in 2018, at CAGR of 7.5%. Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays are driving the growth of the market. In this report, the market has been categorized based on product & service, type, technology, application, and end user. Based on product and service, the multiplex assays...
  • タンパク質結合アッセイの世界市場予測（～2023年）：平衡透析、限外ろ過、超遠心分離、ゲルろ過クロマトグラフィー
    BT-6524 / MarketsandMarkets / 2018年8月10日 / MarketsandMarketsが発行した当調査レポートでは、タンパク質結合アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、技術別（平衡透析、限外ろ過、超遠心分離、ゲルろ過クロマトグラフィー）分析、エンドユーザー別（製薬会社・バイオテクノロジー企業、開発業務受託機関）分析、タンパク質結合アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global protein binding assay market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at CAGR of 10.7% during the forecast period. Market growth is largely driven by factors such as the growing number of drug discovery activities, increasing pressure to reduce drug discovery and development costs, and the increase in pharmaceutical R&D expenditure. The growing CRO industry is also expected to provide a wide range of growth opportunities for players in this market. In this report, the market has been categorized based on technology, end user, and region. On the basis of...
  • 遺伝子パネルの世界市場予測（～2023年）
    BT6318 / MarketsandMarkets / 2018年5月29日 / MarketsandMarketsが発行した当調査レポートでは、遺伝子パネルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品・サービス別分析、技術（アンプリコン、ハイブリダイゼーション）別分析、デザイン別分析、用途別分析、遺伝子パネルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global gene panels market is expected to reach USD 2.95 Billion by 2023 from USD 1.22 Billion in 2018, at a CAGR of 19.2%. The growth of this market is mainly driven by the increasing prevalence of chronic diseases, growing company initiatives, and rising adoption of gene panels owing to the benefits they offer. This report segments the gene panels market into product & service, technique, design, application, end user, and region. Based on products & services, the market is segmented into test kits and testing services. In 2018, the test kits segment accounted for the largest share of...
  • ジェノタイピングアッセイの世界市場予測（～2023年）
    BT-3397 / MarketsandMarkets / 2018年11月21日 / ジェノタイピングアッセイの世界市場は、2018年の推定118億米ドルから2023年には319億米ドルに達し、22.0%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、技術の進歩、DNAシーケンシングの価格の低下、および遺伝性疾患の増加が考えれられます。一方で、機器のコストが高いことにより、市場の成長が抑制される可能性があります。当調査レポートでは、ジェノタイピングアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術（PCR、シークエンシング、マイクロアレイ、電気泳動、MALDI-TOF）分析、用途（薬理ゲノミクス、診断研究、動物遺伝学、農業バイオテクノロジー）分析、製品分析、ジェノタイピングアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global genotyping market is projected to grow at a CAGR of 22.0%.”The genotyping market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%. Technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases are expected to drive the growth of the global genotyping market. However, the high cost of equipment is expected to restrain market growth to a certain extent during the forecast period. “Pharmacogenomics application segment to witness the highest growth during the forecast period.” On the basis of application,...
  • ペースメーカーの世界市場予測（～2023年）
    MD-6726 / MarketsandMarkets / 2018年11月5日 / ペースメーカーの市場は、2018年の44億米ドルから2023年には49億米ドルに拡大すると見られており、この期間中の年平均成長率は2.0％と予測されています。この市場の成長は、循環器疾患の蔓延とデバイスの技術的進歩が起因しています。当調査レポートでは、ペースメーカーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、植え込み可能性別（外部）分析、技術別（シングルチャンバー、デュアルチャンバー、CRT-P・両心室ペースメーカー）分析、タイプ別（従来型、MRI対応型）分析、エンドユーザー別（病院・循環器センター、通院外科診療所）分析、ペースメーカーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The pacemaker market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0%. Growth in this market is driven by increasing prevalence of cardiovascular diseases and technological advancements in devices. Pacemakers Market By type, the MRI compatible pacemaker segment is expected to be the faster-growing in the pacemaker market during the forecast period. The MRI compatible pacemakers segment is projected to grow at the higher CAGR between 2018 and 2023. This can be attributed to the growing number of patients with implanted pacemaker and the increasing need for MRI scans...
  • 遺伝子発現解析の世界市場予測（～2023年）
    BT-2236 / MarketsandMarkets / 2018年11月8日 / 遺伝子発現解析の世界市場は、2018年の32億米ドルから2023年には49億米ドルに達し、この期間中に8.8％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、シークエンシングのコストの低下、技術の進歩、がん患者数の増加、政府の資金提供、新しい技術、遺伝子発現の応用分野の拡大、および遺伝子発現データベースの有用性などが考えれられます。一方で、機器のコストが高く、訓練を受けた専門家が不足していることにより、市場の成長が抑制される可能性があります。当調査レポートでは、遺伝子発現解析の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品・サービス（消耗品、機器、サービス）分析、エンドユーザー（製薬・バイオテクノロジー企業、研究センター)分析、遺伝子発現解析の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The gene expression market is projected to grow at a CAGR of 8.8% during the forecast period.”The global gene expression market is projected to reach USD 4.9 billion by 2023 from USD 3.2 billion in 2018 at a CAGR of 8.8%. Growth in the gene expression market can be attributed to factors such as the decreasing cost of sequencing, technological advancements, rise in the number of cancer patients, availability of government funding, novel technologies, growing application areas of gene expression, and availability of gene expression databases. However, high cost of instruments, and shortage of trained professionals may prove to be...
  • クレアチニン測定の世界市場予測（～2023年）：キット、試薬
    BT-6361 / MarketsandMarkets / 2018年6月11日 / MarketsandMarketsが発行した当調査レポートでは、クレアチニン測定の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（キット、試薬）別分析、テスト種類別分析、サンプル別分析、需要先別分析、クレアチニン測定の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 377.2 Million in 2018, at a CAGR of 8.4%. The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives. This report segments the creatinine measurement market on the basis of type, type of sample, end user, product, and region. By type,...
  • 分子診断の世界市場予測（～2023年）
    MD2521 / MarketsandMarkets / 2018年5月24日 / MarketsandMarketsが発行した当調査レポートでは、分子診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途（感染症、がん診断、遺伝子検査）別分析、技術別分析、需要先別分析、製品・サービス別分析、分子診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global molecular diagnostics market is projected to grow at a CAGR of 8.4%.”The global molecular diagnostics market is expected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4%. Growth in this market can primarily be attributed to the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. However, complex regulatory frameworks delaying the approval of new molecular diagnostic tests are expected to restrain the growth of this market...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆